Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Thu 13 Sep 2007, 17:33 ENL- Enaleni - Enaleni Pharmaceuticals to resume m
ENL
 ENL                                                                             
ENL- Enaleni - Enaleni Pharmaceuticals to resume manufacturing on selected lines
Enaleni Pharmaceuticals Limited                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number 2002/018027/06)                                            
JSE code: ENL   &    ISIN: ZAE000067740                                         
("Enaleni")                                                                     
Enaleni Pharmaceuticals to resume manufacturing on selected lines               
Shareholders are advised as follows:                                            
Enaleni Pharmaceuticals Ltd has received Medicines Control Council approval to  
resume production on certain contract manufacturing lines, namely the Dettol and
Disprin ranges, in a new upgraded interim production area.                      
Since halting production at the end of June, Enaleni has fast-tracked work on   
its upgrade to international PIC/S compliance and constructed an interim        
production area with an independent, balanced and qualified HVAC system and two 
new GIGA Press machines, each capable of producing 4500 tablets per minute.     
Staff who will be working in the new area have already received substantial cGMP
(Good Manufacturing Practice) and related training relevant to the manufacturing
processes.                                                                      
The upgrade to the 10 000m2 Durban-based manufacturing site remains on target   
and budget, and the final phase is due for completion in April 2008.            
Durban                                                                          
13 September 2007                                                               
Sponsor                                                                         
Nedbank Capital                                                                 
Date: 13/09/2007 17:33:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: